118 related articles for article (PubMed ID: 11916147)
1. Evaluation of 7-hydroxy-flavones as inhibitors of oestrone and oestradiol biosynthesis.
Vinh TK; Nicholls PJ; Kirby AJ; Simons C
J Enzyme Inhib; 2001 Nov; 16(5):417-24. PubMed ID: 11916147
[TBL] [Abstract][Full Text] [Related]
2. Inhibitors of human and rat testes microsomal 17beta-hydroxysteroid dehydrogenase (17beta-HSD) as potential agents for prostatic cancer.
Le Lain R; Nicholls PJ; Smith HJ; Maharlouie FH
J Enzyme Inhib; 2001 Jan; 16(1):35-45. PubMed ID: 11496833
[TBL] [Abstract][Full Text] [Related]
3. Chalcones are potent inhibitors of aromatase and 17beta-hydroxysteroid dehydrogenase activities.
Le Bail JC; Pouget C; Fagnere C; Basly JP; Chulia AJ; Habrioux G
Life Sci; 2001 Jan; 68(7):751-61. PubMed ID: 11205867
[TBL] [Abstract][Full Text] [Related]
4. N-Butyl-N-methyl-11-(3'-hydroxy-21', 17'-carbolactone-19'-nor-17'alpha-pregna-1',3', 5'(10')-trien-7'alpha-yl)-undecanamide: an inhibitor of type 2 17beta-hydroxysteroid dehydrogenase that does not have oestrogenic or androgenic activity.
Sam K; Labrie F; Poirier D
Eur J Med Chem; 2000 Feb; 35(2):217-25. PubMed ID: 10758283
[TBL] [Abstract][Full Text] [Related]
5. Aromatase and 17beta-hydroxysteroid dehydrogenase inhibition by flavonoids.
Le Bail JC; Laroche T; Marre-Fournier F; Habrioux G
Cancer Lett; 1998 Nov; 133(1):101-6. PubMed ID: 9929167
[TBL] [Abstract][Full Text] [Related]
6. 1-[(Benzofuran-2-yl)phenylmethyl]triazoles as steroidogenic inhibitors: synthesis and in vitro inhibition of human placental CYP19 aromatase.
Vinh TK; Yee SW; Kirby AJ; Nicholls PJ; Simons C
Anticancer Drug Des; 2001; 16(4-5):217-25. PubMed ID: 12049480
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, biochemical evaluation and rationalisation of the inhibitory activity of a range of 4-hydroxyphenyl ketones as potent and specific inhibitors of the type 3 of 17beta-hydroxysteroid dehydrogenase (17beta-HSD3).
Lota RK; Olusanjo MS; Dhanani S; Owen CP; Ahmed S
J Steroid Biochem Mol Biol; 2008 Jul; 111(1-2):128-37. PubMed ID: 18620056
[TBL] [Abstract][Full Text] [Related]
8. Some coumarins and triphenylethene derivatives as inhibitors of human testes microsomal 17beta-hydroxysteroid dehydrogenase (17beta-HSD type 3): further studies with tamoxifen on the rat testes microsomal enzyme.
LE Lain R; Barrell KJ; Saeed GS; Nicholls PJ; Simons C; Kirby A; Smith HJ
J Enzyme Inhib Med Chem; 2002 Apr; 17(2):93-100. PubMed ID: 12420755
[TBL] [Abstract][Full Text] [Related]
9. Phytoestrogens inhibit aromatase but not 17beta-hydroxysteroid dehydrogenase (HSD) type 1 in human granulosa-luteal cells: evidence for FSH induction of 17beta-HSD.
Whitehead SA; Lacey M
Hum Reprod; 2003 Mar; 18(3):487-94. PubMed ID: 12615812
[TBL] [Abstract][Full Text] [Related]
10. Effects of phytoestrogens on aromatase, 3beta and 17beta-hydroxysteroid dehydrogenase activities and human breast cancer cells.
Le Bail JC; Champavier Y; Chulia AJ; Habrioux G
Life Sci; 2000 Feb; 66(14):1281-91. PubMed ID: 10755463
[TBL] [Abstract][Full Text] [Related]
11. The effect of epitestosterone on estrogen biosynthesis in vitro.
Bicíková M; Klak J; Hill M; Stárka L
Horm Metab Res; 2000 Apr; 32(4):125-8. PubMed ID: 10824706
[TBL] [Abstract][Full Text] [Related]
12. Steroidal spiro-gamma-lactones that inhibit 17 beta-hydroxysteroid dehydrogenase activity in human placental microsomes.
Sam KM; Auger S; Luu-The V; Poirier D
J Med Chem; 1995 Oct; 38(22):4518-28. PubMed ID: 7473580
[TBL] [Abstract][Full Text] [Related]
13. Retinoic acids promote the action of aromatase and 17beta-hydroxysteroid dehydrogenase type 1 on the biosynthesis of 17beta-estradiol in placental cells.
Zhu SJ; Li Y; Li H; Wang YL; Xiao ZJ; Vihko P; Piao YS
J Endocrinol; 2002 Jan; 172(1):31-43. PubMed ID: 11786372
[TBL] [Abstract][Full Text] [Related]
14. A 6beta-(thiaheptanamide) derivative of estradiol as inhibitor of 17beta-hydroxysteroid dehydrogenase type 1.
Poirier D; Dionne P; Auger S
J Steroid Biochem Mol Biol; 1998 Jan; 64(1-2):83-90. PubMed ID: 9569013
[TBL] [Abstract][Full Text] [Related]
15. Dithioerythritol (DTE) prevents inhibitory effects of triphenyltin (TPT) on the key enzymes of the human sex steroid hormone metabolism.
Lo S; Alléra A; Albers P; Heimbrecht J; Jantzen E; Klingmüller D; Steckelbroeck S
J Steroid Biochem Mol Biol; 2003 Apr; 84(5):569-76. PubMed ID: 12767282
[TBL] [Abstract][Full Text] [Related]
16. Mammalian lignans and genistein decrease the activities of aromatase and 17beta-hydroxysteroid dehydrogenase in MCF-7 cells.
Brooks JD; Thompson LU
J Steroid Biochem Mol Biol; 2005 Apr; 94(5):461-7. PubMed ID: 15876411
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of 17beta-hydroxysteroid oxidoreductase by flavonoids in breast and prostate cancer cells.
Mäkelä S; Poutanen M; Kostian ML; Lehtimäki N; Strauss L; Santti R; Vihko R
Proc Soc Exp Biol Med; 1998 Mar; 217(3):310-6. PubMed ID: 9492340
[TBL] [Abstract][Full Text] [Related]
18. Spironolactone-related inhibitors of type II 17beta-hydroxysteroid dehydrogenase: chemical synthesis, receptor binding affinities, and proliferative/antiproliferative activities.
Tremblay MR; Luu-The V; Leblanc G; Noël P; Breton E; Labrie F; Poirier D
Bioorg Med Chem; 1999 Jun; 7(6):1013-23. PubMed ID: 10428369
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of substituted 15β-alkoxy estrone derivatives and their cofactor-dependent inhibitory effect on 17β-HSD1.
Herman BE; Kiss A; Wölfling J; Mernyák E; Szécsi M; Schneider G
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1271-1286. PubMed ID: 31307240
[TBL] [Abstract][Full Text] [Related]
20. Estradiol and estrone C-16 derivatives as inhibitors of type 1 17beta-hydroxysteroid dehydrogenase: blocking of ER+ breast cancer cell proliferation induced by estrone.
Laplante Y; Cadot C; Fournier MA; Poirier D
Bioorg Med Chem; 2008 Feb; 16(4):1849-60. PubMed ID: 18035543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
